Health insurer Anthem eases restrictions on Sarepta`s Duchenne treatment

Published 7y ago

Health insurer Anthem Inc has eased access to Sarepta Therapeutics' treatment for Duchenne muscular dystrophy, and on Thursday changed its reimbursement policy on its website to "medically necessary." More »